LENZ Therapeutics Inc (LENZ)

LENZ Therapeutics Inc (LENZ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $102M; returns 1 day -2.8%, 1 week -3.4%, 1 year -89.9%.

LENZ Therapeutics Inc. is a commercial-stage pharmaceutical company focused on developing and commercializing specialty ophthalmic therapies to improve vision. The company's primary driver of value and commercial revenue is VIZZ (aceclidine ophthalmic solution 1.44%), a once-daily, pupil-selective miotic eye drop designed to treat presbyopia (age-related loss of near vision). Approved by the U.S.

Groups LENZ belongs to

• Ophthalmology
• Commercial Stage
• Commercial Stage Biotech
• Biopharmaceutical
• Pharmaceuticals
• Healthcare
• Biotechnology

LENZ financial model: income statement, cash flow and balance sheet